Literature DB >> 26077468

Role of high-mobility group box 1 protein in inflammatory bowel disease.

Zhen Hu1, Xiaoyun Wang, Lei Gong, Gaojue Wu, Xiaobin Peng, Xuejun Tang.   

Abstract

High-mobility group box 1 (HMGB1) protein is a nuclear non-histone DNA-binding protein. It is released into the extracellular milieu and mediates inflammatory responses, which contribute to the pathogenesis of numerous inflammatory diseases, including inflammatory bowel disease (IBD). An online search was performed in PubMed and Web of Science databases for articles providing evidence on the role of HMGB1 in IBD. HMGB1 plays an important role in IBD pathogenesis. Application of HMGB1 antagonists reduced inflammatory reactions and ameliorated colitis in rodent models, which may provide new insights into the diagnosis and treatment of IBD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077468     DOI: 10.1007/s00011-015-0841-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  63 in total

Review 1.  HMG1 and 2: architectural DNA-binding proteins.

Authors:  J O Thomas
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

2.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

3.  Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Authors:  Hiromasa Takaishi; Takanori Kanai; Atsushi Nakazawa; Fumihiko Sugata; Akira Nikai; Shigeo Yoshizawa; Yasuo Hamamoto; Shinsuke Funakoshi; Tomoharu Yajima; Yasushi Iwao; Masao Takemura; Shoichi Ozaki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-05-30       Impact factor: 7.527

4.  Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages.

Authors:  Xianghong Zhang; David Wheeler; Ying Tang; Lanping Guo; Richard A Shapiro; Thomas J Ribar; Anthony R Means; Timothy R Billiar; Derek C Angus; Matthew R Rosengart
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.

Authors:  Masayuki Fukata; Limin Shang; Rebeca Santaolalla; John Sotolongo; Cristhine Pastorini; Cecilia España; Ryan Ungaro; Noam Harpaz; Harry S Cooper; Greg Elson; Marie Kosco-Vilbois; Julia Zaias; Maria T Perez; Lloyd Mayer; Arunan S Vamadevan; Sergio A Lira; Maria T Abreu
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

6.  Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC).

Authors:  J Sobajima; S Ozaki; H Uesugi; F Osakada; H Shirakawa; M Yoshida; K Nakao
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins.

Authors:  G H Goodwin; E W Johns
Journal:  Methods Cell Biol       Date:  1977       Impact factor: 1.441

8.  Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Authors:  Huan Yang; Peter Lundbäck; Lars Ottosson; Helena Erlandsson-Harris; Emilie Venereau; Marco E Bianchi; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Daniel J Antoine
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

9.  Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

Authors:  Ju-Hyun Kim; Seon-Ju Kim; Im-Soon Lee; Myung-Shik Lee; Satoshi Uematsu; Shizuo Akira; Kwon Ik Oh
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending.

Authors:  Fabricio S Belgrano; Isabel C de Abreu da Silva; Francisco M Bastos de Oliveira; Marcelo R Fantappié; Ronaldo Mohana-Borges
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

View more
  9 in total

Review 1.  Dysfunction of epithelial permeability barrier induced by HMGB1 in 2.5D cultures of human epithelial cells.

Authors:  Takashi Kojima; Yuma Shindo; Takumi Konno; Yuki Kodera; Wataru Arai; Maki Miyakawa; Kizuku Ohwada; Hiroki Tanaka; Mitsuhiro Tsujiwaki; Yuji Sakuma; Shin Kikuchi; Tsuyoshi Ohkuni; Kenichi Takano; Atsushi Watanabe; Takayuki Kohno
Journal:  Tissue Barriers       Date:  2021-09-18

2.  Pyk2 inhibitor prevents epithelial hyperpermeability induced by HMGB1 and inflammatory cytokines in Caco-2 cells.

Authors:  Takumi Konno; Takayuki Kohno; Maki Miyakawa; Hiroki Tanaka; Takashi Kojima
Journal:  Tissue Barriers       Date:  2021-03-04

3.  HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.

Authors:  Varun Chandrashekaran; Ratanesh K Seth; Diptadip Dattaroy; Firas Alhasson; Jacek Ziolenka; James Carson; Franklin G Berger; Balaraman Kalyanaraman; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Redox Biol       Date:  2017-05-10       Impact factor: 11.799

4.  HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation.

Authors:  Xuan Tao; Mingyang Sun; Min Chen; Rongchao Ying; Wenjie Su; Jian Zhang; Xiaodong Xie; Wei Wei; Xiaohu Meng
Journal:  Stem Cell Res Ther       Date:  2019-03-13       Impact factor: 6.832

5.  Glycyrrhizin Ameliorates Radiation Enteritis in Mice Accompanied by the Regulation of the HMGB1/TLR4 Pathway.

Authors:  Xiao-Min Zhang; Xiao Hu; Jin-Ying Ou; Shan-Shan Chen; Ling-Hui Nie; Lei Gao; Ling-Ling Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-31       Impact factor: 2.629

6.  Increase in Epithelial Permeability and Cell Metabolism by High Mobility Group Box 1, Inflammatory Cytokines and TPEN in Caco-2 Cells as a Novel Model of Inflammatory Bowel Disease.

Authors:  Maki Miyakawa; Takumi Konno; Takayuki Kohno; Shin Kikuchi; Hiroki Tanaka; Takashi Kojima
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

7.  Data Driven Mathematical Model of Colon Cancer Progression.

Authors:  Arkadz Kirshtein; Shaya Akbarinejad; Wenrui Hao; Trang Le; Sumeyye Su; Rachel A Aronow; Leili Shahriyari
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

Review 8.  Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.

Authors:  Lorenz Gerbeth; Rainer Glauben
Journal:  Front Med (Lausanne)       Date:  2021-03-26

Review 9.  Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?

Authors:  Armando Rojas; Iván Schneider; Cristian Lindner; Ileana Gonzàlez; Miguel Angel Morales
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.